STRO - Sutro Biopharma GAAP EPS of -$0.95 revenue of $13M May, 13 2024 05:18 PM Sutro Biopharma Inc. 2024-05-13 17:18:12 ET More on Sutro Biopharma BofA starts Sutro at buy, cites ovarian cancer drug candidate Sutro Biopharma prices $75M underwritten offering Seeking Alpha’s Quant Rating on Sutro Biopharma Historical earnings data for Sutro Biopharma Financial information for Sutro Biopharma For further details see: Sutro Biopharma GAAP EPS of -$0.95, revenue of $13M